Astellas To Create Own Sales Network In Former Soviet Nations
This article was originally published in PharmAsia News
Executive SummaryAstellas Pharma plans to establish its own sales network in former Soviet nations, setting up the units by fiscal year 2014
You may also be interested in...
UCB's R&D efforts include late-stage diverse but complementary immunologicals and anti-neuroinflammatories.
Janssen and AstraZeneca are among a raft of companies that might this week find out whether the European Medicines Agency will recommend approval of their products for expanded therapeutic indications.
Shares in Iovance Biotherapeutics have soared this week amid reports the US clinical-stage biotechnology company is in active M&A talks.